Renal carcinoma, commonly referring to renal cell carcinoma (RCC), is a type of cancer that begins in the kidney. Renal cell carcinoma develops from cells in the kidney tubules and is the most common type of kidney cancer in adults.

The appropriate renal carcinoma treatment depends on several factors, including:

• Tumor size

• Location within the kidney

• Whether the tumor has spread outside the kidney

• Lymph-node involvement

• Distant metastases

• Kidney function

• Overall health

• Age and other medical conditions

• Specific renal cell carcinoma subtype

• Patient preferences and treatment goals

There is therefore no single treatment that is appropriate for every person diagnosed with renal carcinoma.

At Prabhakar Bhurke Clinic, Dr. Sandip Prabhakar Bhurke, super specialist nephrologist and transplant physician, provides specialist kidney evaluation and kidney-function management for patients who require coordinated care during and after cancer treatment.

How Is Renal Carcinoma Treatment Decided?

Before choosing treatment, the medical team needs to establish the extent and characteristics of the cancer.

Evaluation may involve:

Imaging

CT or MRI can help determine:

• Tumor size

• Tumor location

• Involvement of nearby structures

• Lymph-node abnormalities

• Possible spread to other organs

Kidney Function Assessment

Blood tests such as serum creatinine and eGFR help determine how well the kidneys are functioning.

This information becomes particularly important when kidney surgery is being considered.

Tissue Diagnosis

A biopsy may be recommended in selected situations to establish the tumor type or guide treatment decisions.

The need for biopsy depends on the clinical and imaging findings.

Cancer Staging

Staging determines whether the cancer is localized, locally advanced or metastatic.

Treatment options change substantially as the extent of disease changes.

Renal Carcinoma Treatment for Localized Kidney Cancer

When renal carcinoma is confined to the kidney, treatment often focuses on controlling or removing the tumor while preserving as much healthy kidney tissue as safely possible.

Depending on the circumstances, options may include:

• Partial nephrectomy

• Radical nephrectomy

• Thermal ablation

• Cryotherapy

• Stereotactic body radiation therapy in selected patients

• Active surveillance in carefully selected situations

• Clinical trials

Surgery remains a major treatment approach for localized renal cell carcinoma.

Partial Nephrectomy for Renal Carcinoma

A partial nephrectomy removes the cancerous portion of the kidney while preserving the remaining healthy kidney tissue.

This kidney-sparing approach may be particularly valuable when:

• The tumor is relatively small

• The tumor can be removed safely while preserving kidney tissue

• The patient has reduced kidney function

• The opposite kidney has impaired function

• There is a risk of future kidney disease

For appropriately selected early kidney cancers, partial nephrectomy can provide cancer control while preserving more renal tissue.

The feasibility of partial nephrectomy depends on tumor position, complexity and the surgeon's assessment.

Radical Nephrectomy in Renal Cell Carcinoma

A radical nephrectomy involves removal of the affected kidney along with surrounding tissues and, depending on the situation, other nearby structures.

It may be considered when:

• The tumor is large or complex

• The tumor cannot be safely removed with partial nephrectomy

• The cancer extends into surrounding structures

• Kidney-sparing surgery is not technically appropriate

The decision requires consideration of both cancer control and the patient's remaining kidney function.

If the other kidney is healthy, many patients can maintain adequate kidney function with one functioning kidney. However, kidney function should continue to be monitored after nephrectomy.

Can Kidney Function Be Preserved During Cancer Treatment?

Preserving kidney function is an important consideration in renal carcinoma care.

The medical team may evaluate:

• Baseline creatinine

• eGFR

• Urine albumin or protein

• Blood pressure

• Diabetes

• Cardiovascular disease

• Function of the opposite kidney

Patients with pre-existing CKD, a solitary kidney or disease affecting both kidneys may require particularly careful planning.

This is one reason nephrology involvement can be useful when kidney cancer treatment may substantially affect renal function.

Treatment When Surgery Is Not Suitable

Not every patient with localized renal carcinoma is an appropriate surgical candidate.

Depending on tumor characteristics and the patient's health, alternative local treatments may include:

Thermal Ablation

Techniques such as thermal ablation can destroy selected kidney tumors using controlled energy.

Cryotherapy

Cryotherapy uses extreme cold to destroy tumor tissue.

Stereotactic Body Radiation Therapy

Highly focused radiation can be considered for selected patients who cannot undergo surgery.

These approaches are not interchangeable, and suitability depends on tumor location, size, kidney function and overall health.

Renal Carcinoma Treatment After Surgery

Surgery may successfully remove localized kidney cancer, but some patients have a higher risk of recurrence.

After surgery, doctors may consider:

• Pathology results

• Tumor stage

• Tumor grade

• Lymph-node involvement

• Surgical margins

• Other high-risk characteristics

For selected patients with clear-cell renal cell carcinoma at high risk of recurrence, adjuvant pembrolizumab may be considered after surgery. Clinical evidence has shown an overall-survival benefit in appropriately selected high-risk patients.

Not every patient requires postoperative immunotherapy.

Treatment of Advanced or Metastatic Renal Cell Carcinoma

When renal carcinoma has spread beyond the kidney, treatment usually involves a broader cancer-management strategy.

Depending on the cancer subtype and risk group, treatment may include:

• Immunotherapy

• Targeted therapy

• Combination systemic treatment

• Selected surgery

• Radiation therapy for specific problems

• Clinical trials

Modern treatment for advanced renal cell carcinoma commonly uses combinations involving immune checkpoint inhibitors and targeted agents.

Examples of systemic treatment approaches include combinations such as:

• Nivolumab plus ipilimumab

• Pembrolizumab plus axitinib

• Pembrolizumab plus lenvatinib

• Nivolumab plus cabozantinib

The most appropriate regimen depends on disease characteristics, risk category, previous treatment and the patient's health.

What Is Immunotherapy for Renal Cell Carcinoma?

Immunotherapy uses medicines that help the immune system recognize and attack cancer cells.

Immune checkpoint inhibitors have become an important component of treatment for advanced renal cell carcinoma.

Examples include medicines targeting pathways such as:

• PD-1

• PD-L1

• CTLA-4

Immunotherapy may be used alone in selected situations or combined with another immunotherapy or targeted medicine.

Because these treatments can affect organs throughout the body, patients require appropriate monitoring during therapy.

What Is Targeted Therapy for Kidney Cancer?

Targeted therapies act on specific molecular pathways involved in tumor growth and blood-vessel formation.

Medicines used in renal cell carcinoma treatment may target pathways involving:

• VEGF

• VEGF receptors

• mTOR

• Other molecular targets

Examples of targeted medicines used in renal cell carcinoma include axitinib, cabozantinib, lenvatinib, everolimus and other agents depending on the clinical situation.

Targeted therapy is selected according to cancer subtype, previous treatments, risk category and overall treatment strategy.

Is Chemotherapy Used for Renal Cell Carcinoma?

Traditional chemotherapy has a limited role in typical renal cell carcinoma compared with surgery, immunotherapy and targeted treatments.

The treatment strategy depends strongly on the exact kidney cancer subtype.

Some less common kidney cancers behave differently and may require different systemic therapies.

Therefore, treatment should be based on the pathology and specialist cancer assessment rather than simply the term “kidney cancer.”

Can Renal Carcinoma Be Cured?

The possibility of cure depends strongly on the stage and biological characteristics of the cancer.

When renal cell carcinoma is detected while it remains localized, treatment can often achieve long-term disease control and may be curative.

Advanced metastatic disease is more difficult to cure, but modern systemic treatments can provide meaningful disease control for some patients.

The prognosis cannot be accurately determined from tumor size alone.

What Happens if Renal Carcinoma Has Spread?

If cancer has spread to organs such as the:

• Lungs

• Liver

• Bones

• Brain

• Distant lymph nodes

the treatment plan generally requires systemic cancer therapy and may also include carefully selected local treatments.

Surgery to remove the kidney is not automatically required for every person with metastatic renal carcinoma.

In selected patients, nephrectomy may still have a role depending on disease burden, symptoms, overall health and response to systemic treatment.

Renal Carcinoma and Kidney Failure

Kidney cancer does not automatically cause kidney failure.

However, kidney function may be affected by:

• Removal of one kidney

• Pre-existing CKD

• Tumor involvement of kidney tissue

• Treatment-related effects

• Dehydration

• High blood pressure

• Diabetes

• Other medical conditions

Patients with reduced renal reserve may benefit from nephrology monitoring before and after cancer treatment.

If both kidneys become severely dysfunctional, kidney replacement therapy such as dialysis or, in appropriately selected patients, transplantation may eventually be considered.

Follow-Up After Renal Carcinoma Treatment

Treatment does not necessarily end when the tumor has been removed.

Follow-up may involve:

• Periodic imaging

• Kidney-function tests

• Blood-pressure monitoring

• Assessment for recurrence

• Medication review

• Monitoring the remaining kidney

• Evaluation of new symptoms

The frequency and type of surveillance depend on the cancer stage, pathology and treatment received.

Lifestyle and Kidney Protection During Cancer Care

Lifestyle measures cannot replace cancer treatment, but they can support general and kidney health.

Avoid Smoking

Smoking is associated with kidney cancer risk and cardiovascular disease.

Maintain Appropriate Blood Pressure

Blood-pressure control is especially important when kidney function has been reduced.

Manage Diabetes

Good diabetes management can help protect the remaining kidney function.

Avoid Unnecessary Kidney-Harming Medicines

Certain medicines, including some NSAIDs, can affect kidney function in susceptible people.

Discuss regular painkiller use with your healthcare professional.

Follow an Individualized Diet

Dietary requirements may change depending on kidney function, cancer treatment, nutritional status and other medical conditions.

Avoid restrictive “cancer diets” or herbal preparations without professional advice.

Can Kidney Cancer Treatment Affect the Remaining Kidney?

Yes, particularly when a person has limited renal reserve before treatment.

After removal of one kidney, the remaining kidney often adapts by increasing its filtration capacity. However, long-term kidney health still needs monitoring.

Patients with:

• Diabetes

• Hypertension

• Proteinuria

• CKD

• A solitary kidney

• Previous kidney injury

may require closer nephrology follow-up.

Why Multidisciplinary Care Matters

Renal carcinoma can involve several areas of medical care.

Depending on the patient's needs, treatment may involve:

• Urologic oncology

• Medical oncology

• Radiation oncology

• Nephrology

• Radiology

• Pathology

• Specialist nursing and supportive care

The exact combination depends on whether the tumor is localized, locally advanced or metastatic.

For patients with existing kidney disease, nephrology input can help balance cancer treatment with preservation of remaining kidney function.

Kidney and Renal Carcinoma Care at Prabhakar Bhurke Clinic

At Prabhakar Bhurke Clinic, Dr. Sandip Prabhakar Bhurke, super specialist nephrologist and transplant physician, provides specialist kidney evaluation for patients who have renal tumors along with kidney-function concerns.

Depending on the patient's condition, nephrology care may include:

• Assessment of baseline kidney function

• Creatinine and eGFR monitoring

• Evaluation of proteinuria

• Blood-pressure management

• Assessment of CKD risk

• Kidney-function monitoring before and after nephrectomy

• Management of kidney-related complications during cancer treatment

• Dialysis-related evaluation when clinically required

• Kidney transplant-related assessment in selected situations

• Coordination with urology and oncology teams when appropriate

Cancer-directed treatment itself should be planned by the appropriate cancer specialists according to the tumor's pathology and stage.

Frequently Asked Questions

What is the best treatment for renal carcinoma?

There is no single best treatment for every patient. Localized disease is often treated surgically, while selected patients may receive ablation or focused radiation. Advanced disease may require immunotherapy, targeted therapy, surgery in selected circumstances or combinations of these approaches.

Is renal carcinoma the same as kidney cancer?

Renal cell carcinoma is the most common type of kidney cancer in adults, but “kidney cancer” can refer to several different tumor types. Treatment depends on the specific cancer diagnosis.

What is the difference between partial and radical nephrectomy?

Partial nephrectomy removes the tumor and a margin of surrounding kidney tissue while preserving the remainder of the kidney. Radical nephrectomy removes the entire affected kidney and surrounding tissues as appropriate.

Can renal carcinoma be treated without removing the kidney?

In selected patients, alternatives such as thermal ablation, cryotherapy or stereotactic radiation may be considered, particularly when surgery is unsuitable. The decision depends on the tumor and the patient's overall condition.

Is immunotherapy used for renal cell carcinoma?

Yes. Immunotherapy is an important treatment option, particularly for advanced renal cell carcinoma, and may also be used after surgery in selected high-risk clear-cell cases.

Can kidney cancer cause kidney failure?

Kidney cancer does not automatically lead to kidney failure. Kidney function may be affected by the disease, surgery, pre-existing kidney conditions or other treatment-related factors.

What happens after kidney cancer surgery?

Follow-up commonly includes cancer surveillance and monitoring of the remaining kidney. The specific schedule depends on the tumor stage, pathology and treatment received.

Conclusion

Renal carcinoma treatment is highly individualized. For cancer confined to the kidney, surgery—particularly partial or radical nephrectomy when appropriate—remains a major treatment approach. Selected patients may instead be considered for ablation or focused radiation.

When renal cell carcinoma has spread, treatment may involve immunotherapy, targeted medicines, selected surgery, radiation or clinical trials. Modern treatment decisions are based on cancer stage, tumor characteristics, overall health and previous therapy.

Protecting kidney function is also an important part of long-term care, particularly for patients with CKD, diabetes, hypertension or a solitary kidney.

For specialist assessment of kidney function and kidney-related care before or after renal carcinoma treatment, consult Dr. Sandip Prabhakar Bhurke at Prabhakar Bhurke Clinic.

Medical Disclaimer

This article is intended for general educational and informational purposes only and should not be considered a substitute for cancer diagnosis, treatment or individualized medical advice. Renal carcinoma treatment depends on the exact tumor type, stage, pathology, tumor location, kidney function, overall health and other clinical factors. Treatment options may include surgery, ablation, radiation, immunotherapy, targeted therapy or combinations of these approaches, but not every option is suitable for every patient. Cancer treatment should be planned by an appropriately qualified multidisciplinary medical team. Do not start, stop or change cancer medicines, supplements or other treatments based solely on this article. Patients with kidney disease should not alter fluid intake, blood-pressure medicines or other prescribed treatment without medical guidance. Consult Dr. Sandip Prabhakar Bhurke and the appropriate urology, oncology or nephrology specialists for an individualized treatment plan.